Advent Pharma Ltd. (DSE:ADVENT)

Advent Pharma Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 9, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Market Capitalization	1,313	1,267	2,384	2,459	2,338	2,274
Market Cap Growth	-12.42%	-46.88%	-3.03%	5.18%	2.82%	20.13%
Enterprise Value	1,386	1,338	2,456	2,530	2,392	2,285
Last Close Price	14.10	13.55	25.34	25.90	24.41	23.56
PE Ratio	22.80	18.94	28.39	24.93	23.97	20.02
PS Ratio	2.54	2.53	4.17	4.41	4.41	4.51
PB Ratio	0.85	0.83	1.62	1.76	1.78	1.84
P/TBV Ratio	0.85	0.83	1.62	1.76	1.78	1.84
P/FCF Ratio	150.40	61.59	182.32	958.68	-	-
P/OCF Ratio	19.24	11.04	13.61	11.98	13.02	12.60
EV/Sales Ratio	2.68	2.67	4.30	4.53	4.51	4.54
EV/EBITDA Ratio	9.56	8.46	11.83	13.05	13.66	13.09
EV/EBIT Ratio	16.69	13.99	17.34	18.69	17.93	16.75
EV/FCF Ratio	158.69	65.04	187.80	986.61	-	-
Debt / Equity Ratio	0.05	0.05	0.05	0.05	0.05	0.05
Debt / EBITDA Ratio	0.52	0.48	0.37	0.37	0.36	0.34
Debt / FCF Ratio	8.68	3.69	5.81	27.92	-	-
Asset Turnover	0.27	0.26	0.31	0.33	0.34	0.35
Inventory Turnover	5.41	4.87	4.68	4.16	3.96	4.01
Quick Ratio	1.22	1.01	0.78	0.62	0.71	1.03
Current Ratio	1.70	1.51	1.28	1.15	1.38	1.72
Return on Equity (ROE)	3.76%	4.46%	5.85%	7.27%	7.66%	9.65%
Return on Assets (ROA)	2.69%	3.15%	4.86%	4.93%	5.27%	5.90%
Return on Invested Capital (ROIC)	3.97%	4.71%	7.61%	7.30%	7.61%	9.73%
Return on Capital Employed (ROCE)	4.70%	5.50%	8.50%	8.60%	9.00%	10.00%
Earnings Yield	4.36%	5.28%	3.52%	4.01%	4.17%	5.00%
FCF Yield	0.66%	1.62%	0.55%	0.10%	-0.49%	-0.16%
Dividend Yield	0.35%	0.37%	0.40%	0.77%	0.82%	0.83%
Payout Ratio	7.57%	22.06%	9.76%	8.93%	22.79%	7.11%
Buyback Yield / Dilution	0.63%	-	-	-	-	-
Total Shareholder Return	0.98%	0.37%	0.40%	0.77%	0.82%	0.83%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.